Article Information
History
- June 20, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Yanfei Wang1,
- Chenxi Xiong2,3,
- Weifeng Yu4,
- Minghao Zhou1,
- Tyler A. Shugg5,
- Fang-Chi Hsu6,
- Michael T. Eadon7,
- Jing Su2,* and
- Qianqian Song1,*
- 1Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Florida, USA
- 2Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indiana, USA
- 3Department of Computer and Information Technology, Purdue University, Indiana, USA
- 4Department of Computer Science, University of Virginia, Virginia, USA
- 5Division of Clinical Pharmacology, Indiana University School of Medicine, Indiana, USA
- 6Biostatistics and Data Science, Wake Forest School of Medicine, North Carolina, USA
- 7Department of Medicine, Indiana University School of Medicine, Indiana, USA
- ↵*Correspondences:
Jing Su, Department of Biostatistics & Health Data, Indiana University School of Medicine, Indianapolis, IN 46202, 317-278-6451, su1{at}iu.edu, Qianqian Song, Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida Gainesville, FL, 32611, qsong1{at}ufl.edu
Posted June 20, 2024.
PCCA variant rs16957301 is a novel AKI risk genotype-specific for patients who receive ICI treatment: Real-world evidence from All of Us cohort
